Conceio G, Heinonen I, Loureno AP, Duncker DJ, Falco-Pires I
However, when the disease involves an extensive body surface area or severely impacts quality of life, systemic therapies are necessary
El descubrimiento del sistema de incretinas ha permitido importantes avances teraputicos para la diabetes tipo 2 y la obesidad
It doesnt carry FDA approval as a finished drug product the way brand-name medications do, but for people who cant access or afford brand-name options, it provides a legitimate and accessible path to GLP-1 treatment
We exposed cell lines that had either Keap1, Nrf2 or Srxn1 tagged with green fluorescent protein (GFP) to a concentration range of DEM and monitored the response of these Nrf2 pathway components using high throughput confocal imaging (Fig